Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Emerging Markets Are an Unlikely Winner of the AI Boom John Crabb AI is Driving the Venture Capital Market — But Not Fixing It Michelle Celarier Dollar Reasserts Itself as Global Tensions Shift Currency Markets Sponsored by CME Group